Corticosteroid Therapy for Severe Community-Acquired Pneumonia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the present study is to assess the efficacy of methylprednisolone as an adjuvant therapy in patients with severe community-acquired pneumonia (CAP) (PSI 4-5). The hypothesis of the study is that methylprednisolone can decrease the mortality of severe CAP without any significant side effects,with reduction of the time to clinical stability and failure rate of treatment.
Epistemonikos ID: a29ef0e30dc1b307f2068b6ae58c87e82c3162ac
First added on: May 12, 2024